ENDRA Life Sciences Inc (NDRA)

Etorro trading 970x250
ENDRA Life Sciences Inc (NDRA) Logo

About ENDRA Life Sciences Inc

ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood for the treatment of nonalcoholic fatty liver disease, as well as temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person’s body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan. Address: 3600 Green Court, Ann Arbor, MI, United States, 48105-1570

ENDRA Life Sciences Inc News and around…

Latest news about ENDRA Life Sciences Inc (NDRA) common stock and company :

ENDRA Life Sciences to Present at the H.C. Wainwright BioConnect Virtual Conference
05 Jan, 2022 FinancialContent

ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, announces that management will present a company overview at the H.C. Wainwright BioConnect Virtual Conference being held January 10-13, 2022. A webcast of the presentation will be available on-demand beginning January 10, 2022 at 7:00 a.m. Eastern time on the Investors section of ENDRA’s website.

Forget Bargains, Play 5 Stocks With Rising P/E Instead
30 Dec, 2021 Yahoo! Finance

Forget undervalued stocks, there is room for upside even in stocks with rising P/E.

ENDRA Life Sciences Announces New Clinical Study Partnership with King’s College Hospital, London
13 Dec, 2021 FinancialContent

ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that King’s College Hospital, London (KCH) is now partnering with ENDRA for a clinical study of ENDRA’s Thermo-Acoustic Enhanced Ultrasound (TAEUS®) device for assessing Non-Alcoholic Fatty Liver Disease (NAFLD).

ENDRA Life Sciences Expands Pharmaceutical Partnerships with VGI Health Technology to Provide TAEUS for Patient Screening and Biomarker Measurement for Phase 2 Study
29 Nov, 2021 FinancialContent

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), and VGI Health Technology Limited (NSX: VTL), a clinical-stage biotechnology company specializing in developing and commercializing evidence-based nutraceuticals and pharmaceuticals, announce today the signing of a collaboration agreement to incorporate ENDRA’s proprietary TAEUS technology to support patient screening and biomarker measurement during VGI’s upcoming Phase 2 study of IVB001 in Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH).

12 Health Care Stocks Moving In Wednesday's After-Market Session
17 Nov, 2021 FinancialContent

Gainers Rani Therapeutics Hldgs (NASDAQ:RANI) stock rose 7.36% to $35.0 during Wednesday's after-market session. The ...

ENDRA Life Sciences Further Strengthens TAEUS® System Intellectual Property with Issuance of 22nd and 23rd U.S. Patents
16 Nov, 2021 FinancialContent

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the United States Patent and Trademark Office has issued two patents, including U.S. Patent No. 11172829 (the ‘829 patent) titled “Thermoacoustic Transducer With Integrated Switch,” and U.S. Patent No. 11176848 (the ‘848 patent) titled “Tissue-mimicking Material for A Multi-modality Imaging Phantom.”

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
16 Nov, 2021 FinancialContent

Gainers Kezar Life Sciences (NASDAQ:KZR) stock rose 48.27% to $12.47 during Tuesday's pre-market session. The market ...

The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment
16 Nov, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Kezar Life Sciences Reports ...

ENDRA Life Sciences Inc. (NDRA) Reports Q3 Loss, Misses Revenue Estimates
15 Nov, 2021 Yahoo! Finance

ENDRA Life Sciences Inc. (NDRA) delivered earnings and revenue surprises of 14.29% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

12 Health Care Stocks Moving In Monday's After-Market Session
15 Nov, 2021 FinancialContent

Gainers Kezar Life Sciences (NASDAQ:KZR) shares increased by 29.48% to $10.89 during Monday's after-market session. At the close, ...

ENDRA Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update
15 Nov, 2021 FinancialContent

ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three months ended September 30, 2021 and provided a business update. Highlights of the third quarter of 2021 and recent weeks include:

Earnings Scheduled For November 15, 2021
15 Nov, 2021 FinancialContent

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third ...

ENDRA Life Sciences to Report Third Quarter 2021 Financial Results on November 15, 2021
08 Nov, 2021 FinancialContent

ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial results for the third quarter of 2021 on Monday, November 15, 2021 after the close of trading on the U.S. financial markets. Management will host a conference call and webcast beginning at 4:30 p.m. Eastern time to discuss the results, provide an update on recent corporate developments and answer questions.

ENDRA Life Sciences Further Strengthens TAEUS® System Intellectual Property Protection with Issuance of 21st U.S. Patent
13 Oct, 2021 FinancialContent

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), has recently been issued U.S. Patent 11147067 (the ‘067 patent) titled, “Method And System For Monitoring Tissue Temperature” from the United States Patent & Trademark Office.

ENDRA Life Sciences to Participate in the H.C. Wainwright 5th Annual NASH Investor Conference
05 Oct, 2021 FinancialContent

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will participate in the H.C. Wainwright 5th Annual NASH Investor Conference on Tuesday, October 12, 2021. Management will deliver a company presentation at 2:00 p.m. Eastern Time and will be available for virtual one-on-one meetings with investors throughout the day.

ENDRA Life Sciences to Participate in Two Upcoming Investment Conferences
07 Sep, 2021 FinancialContent
12 Health Care Stocks Moving In Wednesday's Intraday Session
25 Aug, 2021 FinancialContent

Gainers Regencell Bioscience (NASDAQ:RGC) stock rose 100.19% to $30.63 during Wednesday's regular session. Regencell ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
25 Aug, 2021 FinancialContent

Gainers Regencell Bioscience (NASDAQ:RGC) stock increased by 25.49% to $19.2 during Wednesday's pre-market session. ...

ENDRA Life Sciences Reports Second Quarter 2021 Financial Results and Provides Business Update
12 Aug, 2021 FinancialContent
Earnings Scheduled For August 12, 2021
12 Aug, 2021 FinancialContent

Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third ...

ENDRA Life Sciences to Report Second Quarter 2021 Financial Results on August 12, 2021
02 Aug, 2021 FinancialContent
ENDRA Life Sciences Announces Participation in A.G.P.'s Virtual MedTech Summer Conference on July 29, 2021
20 Jul, 2021 FinancialContent
12 Health Care Stocks Moving In Thursday's After-Market Session
08 Jul, 2021 FinancialContent

Gainers Dare Bioscience (NASDAQ:DARE) stock increased by 8.45% to $2.17 during Thursday's after-market session. Dare Bioscience's ...

ENDRA Life Sciences Strengthens TAEUS(R) System Intellectual Property Protection with the Issuance of Three U.S. Patents
07 Jul, 2021 FinancialContent
ENDRA Life Sciences (NASDAQ:NDRA) Is In A Good Position To Deliver On Growth Plans
25 Jun, 2021 Yahoo! Finance

There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, ENDRA Life...

ENDRA Life Sciences Appoints Irina Pestrikova as Senior Director of Finance, Announces Departure of CFO David Wells
15 Jun, 2021 FinancialContent
12 Health Care Stocks Moving In Friday's Pre-Market Session
11 Jun, 2021 FinancialContent

Gainers GBS (NASDAQ:GBS) stock increased by 41.04% to $5.12 during Friday's pre-market session. Novan ...

ENDRA Life Sciences Set to Join the Russell Microcap(R) Index
09 Jun, 2021 FinancialContent
24 Stocks Moving in Tuesday's Pre-Market Session
01 Jun, 2021 FinancialContent

Gainers Vertex Energy, Inc. (NASDAQ: VTNR) rose 43.5% to $11.21 in pre-market trading. Vertex Energy, shares jumped around 96% on ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
01 Jun, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back from the holiday weekend and let's get right into it with a look at the biggest pre-market stock movers for Tuesday. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now It doesn’t matter if you have $500 in savings or $5 million. Do this now. Top Stock Picker Reveals His Next Potential 500% Winner

ENDRA Life Sciences Inc (NDRA) is a NASDAQ Common Stock listed in , ,

970x250